Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BrainStorm Cell Therapeutics has contracted with the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute as a second U.S. manufacturing site to supply NurOwn.
read more
Friday, February 12, 2021
BrainStorm recently concluded a Type C meeting with the FDA to review aspects of the company's planned manufacturing modifications to support the development of a semi-automated commercial manufacturing process for NurOwn.
read more
Wednesday, November 08, 2017
Bracket announced the addition of Christopher Crucitti, Chief Commercial Officer to its global executive team.
read more
Saturday, September 25, 2021
Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. today announced their partnership to launch a new network of mobile CGT manufacturing facilities. The two companies are combining deep logistics, CGT...
read more
Tuesday, September 03, 2019
Bora has reported a successful FDA general inspection for its facility in Zhunan, Taiwan.
read more
Bora Pharmaceuticals and GSK have entered into an agreement under which Bora Pharmaceuticals will acquire GSK's Mississauga, Ontario (Canada) facility.
read more
Thursday, September 22, 2022
Bora Pharmaceutical Labs, a division of Bora Pharmaceuticals, partnered with TaiRx, a Taiwanese drug development company, to manufacture a novel anticancer drug, CVM-1118.
read more
Wednesday, December 02, 2020
Bora Pharmaceuticals announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics.
read more
Bora has announced the opening of its first North American office in Delaware, U.S.
read more
Thursday, September 15, 2022
Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic ...
read more
Tuesday, December 15, 2020
Bora announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Wednesday, December 04, 2019
Bora has announced the appointment of Samuel Ricchezza as President of North America Operations.
read more
Monday, November 25, 2019
Bora has announced the appointment of Sam Ricchezza as President of North American operations.
read more
Bora Pharmaceuticals has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more